These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10171744)

  • 21. Ways to reduce mental health costs.
    Emerson JD
    J Health Care Benefits; 1994; 3(4):45-9. PubMed ID: 10132439
    [No Abstract]   [Full Text] [Related]  

  • 22. Financial costs of alcoholism treatment programs: a longitudinal and comparative evaluation among four specialized centers.
    Nalpas B; Combescure C; Pierre B; Ledent T; Gillet C; Playoust D; Danel T; Bozonnat MC; Martin S; Balmès JL; Daurès JP
    Alcohol Clin Exp Res; 2003 Jan; 27(1):51-6. PubMed ID: 12544005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state.
    Wickizer TM; Krupski A; Stark KD; Mancuso D; Campbell K
    Milbank Q; 2006; 84(3):555-76. PubMed ID: 16953810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An OD comprehensive wellness strategy to identify, assess, and attenuate the causes and costs of employee stress.
    Chamberlain MR
    J Health Hum Resour Adm; 1994; 16(4):445-71. PubMed ID: 10137177
    [No Abstract]   [Full Text] [Related]  

  • 25. Inpatient and outpatient outcomes in Missouri's alcohol and drug treatment programs.
    Hartmann DJ; Sullivan WP; Wolk JL
    J Health Soc Policy; 1993; 5(2):67-76. PubMed ID: 10171763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting substance abuse.
    Gemignani J
    Bus Health; 1997 Feb; 15(2):53-4. PubMed ID: 10172895
    [No Abstract]   [Full Text] [Related]  

  • 27. Health care utilization of carpenters with substance abuse-related diagnoses.
    Lipscomb HJ; Dement JM; Li L
    Am J Ind Med; 2003 Feb; 43(2):120-31. PubMed ID: 12541266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A research agenda for economic evaluation of substance abuse services.
    French MT; Drummond M
    J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A union's view of employee assistance programs.
    Abraham J
    Corp Comment; 1985 Mar; 1(3):40-3. PubMed ID: 10317583
    [No Abstract]   [Full Text] [Related]  

  • 31. Economic costs of drug abuse: financial, cost of illness, and services.
    Cartwright WS
    J Subst Abuse Treat; 2008 Mar; 34(2):224-33. PubMed ID: 17596904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second opinion programs: continued savings from nonconfirmed surgeries.
    Chu A; Lavoie V; McCarthy EG
    Empl Benefits J; 1992 Sep; 17(3):35-40. PubMed ID: 10171221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How many people need substance abuse treatment in North Carolina and how much does it cost?
    McCarthy P; Kissling G; Dirkers J
    N C Med J; 1993 May; 54(5):209-12. PubMed ID: 8389988
    [No Abstract]   [Full Text] [Related]  

  • 35. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes.
    Humphreys K; Moos RH
    Alcohol Clin Exp Res; 2007 Jan; 31(1):64-8. PubMed ID: 17207103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administrative issues related to addiction in the workplace.
    Roberts S; Fallon LF
    Occup Med; 2001; 16(3):509-15, v. PubMed ID: 11401795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team.
    Holland P; Mushinski M
    Stat Bull Metrop Insur Co; 1999; 80(4):2-9. PubMed ID: 10553265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the economic costs of the abuse of tobacco, alcohol and illicit drugs: a review of methodologies and Canadian data sources.
    Choi BC; Robson L; Single E
    Chronic Dis Can; 1997; 18(4):149-65. PubMed ID: 9445363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forecasting the cost of drug abuse treatment coverage in private health insurance.
    McGuire TG; Shatkin BF
    NIDA Res Monogr; 1991; 113():175-89. PubMed ID: 1762639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.